Home
>
US Stocks
>
Fate Therapeutics Inc
Fate Therapeutics Inc
FATE

Fate Therapeutics Inc (FATE)

$60.1115.64%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
59.88
Today Low/High
59.53 / 61.24
52 Week Low/High
$29.37 / $121.16
Market Cap
$8.04B

Company Details

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer. The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company's immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). The Company's immuno-regulatory product candidates include ProTmune™, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease. Fate Therapeutics is headquartered in San Diego, CA.
Organisation
Fate Therapeutics Inc
Headquaters
San Diego, California, US
Employees
279
Industry
Health Technology
CEO
William Rastetter

Discover more

Frequently Asked Questions

What is Fate Therapeutics Inc (FATE) share price today?

Can Indians buy Fate Therapeutics Inc (FATE) shares?

How can I buy Fate Therapeutics Inc (FATE) shares from India?

Can Fractional shares of Fate Therapeutics Inc (FATE) be purchased?

What are the documents required to start investing in Fate Therapeutics Inc (FATE) stocks?

We are a SEBI registered investement advisor